Cargando…
Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals
Coronavirus disease 2019 (COVID-19) may occur with concurrent infections caused by bacterial and fungal microorganisms. This systematic review evaluated studies reporting concomitant COVID-19 and Pneumocystis jirovecii pneumonia (PJP). We found 39 patients (74% male, median age: 56.8 (range: 11–83)...
Autores principales: | Gioia, Francesca, Albasata, Hanan, Hosseini-Moghaddam, Seyed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225243/ https://www.ncbi.nlm.nih.gov/pubmed/35736068 http://dx.doi.org/10.3390/jof8060585 |
Ejemplares similares
-
Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022) -
Pneumocystis jirovecii Transmission from Immunocompetent Carriers to Infant
por: Rivero, Laura, et al.
Publicado: (2008) -
Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
por: Bhat, Pavan, et al.
Publicado: (2020) -
Hypothetical Pneumocystis jirovecii Transmission from Immunocompetent Carriers to Infant
por: Hauser, Philippe, et al.
Publicado: (2009) -
SARS-CoV-2 or Pneumocystis jirovecii? A case report()
por: González Moyano, A.B., et al.
Publicado: (2021)